JAGXJaguar Health, Inc.

JAGX Stock Price, Valuation & Chart | Jaguar Health, Inc.

Compare

$0.730+0.00 (-0.15%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology JAGX intrinsic value JAGX calculated fair value vs price

Overview Financials Dividends Ratios

JAGX Historical price chart

JAGX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization48.64K

PE Ratio-0.02

EPS-43.74

Trading Volume118.62K

Today's High/Low0.76/0.71

Dividend Yield0.00

52 Week High/Low85.4/0.71

Shares Outstanding66.64K

JAGX Financial Statement

JAGX Analyst ratings

JAGX Analysis & performance metrics

JAGX Company profile

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress,…

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on…

JAGX Management team

Name

Position

Ian H. Wendt M.B.A.

Chief Commercial Officer

Lisa A. ConteCEO

Founder, Chief Executive Officer, President & Director

Karen J. Brunke Ph.D.

Executive Vice President of Corporate & Business Development

Peter HodgeCTO

Senior Director of Investor Relations, Business Development & Special Events

Massimo Radaelli M.B.A., Ph.D.

President of Jaguar International

David Sesin Ph.D.

Chief Manufacturing Officer

Pravin R. Chaturvedi Ph.D.

Chief Scientific Officer & Chair of Scientific Advisory Board

Jonathan S. Wolin CPA, J.D., M.B.A.

Chief of Staff, Chief Compliance Officer & General Counsel

Name

Position

Ian H. Wendt M.B.A.

Chief Commercial Officer

Lisa A. ConteCEO

Founder, Chief Executive Officer, President & Director

Karen J. Brunke Ph.D.

Executive Vice President of Corporate & Business Development

Peter HodgeCTO

Senior Director of Investor Relations, Business Development & Special Events

Massimo Radaelli M.B.A., Ph.D.

President of Jaguar International

David Sesin Ph.D.

Chief Manufacturing Officer

Pravin R. Chaturvedi Ph.D.

Chief Scientific Officer & Chair of Scientific Advisory Board

Jonathan S. Wolin CPA, J.D., M.B.A.

Chief of Staff, Chief Compliance Officer & General Counsel

Management Team

Ian H. Wendt M.B.A.

Chief Commercial Officer

Lisa A. ConteCEO

Founder, Chief Executive Officer, President & Director

Karen J. Brunke Ph.D.

Executive Vice President of Corporate & Business Development

Peter HodgeCTO

Senior Director of Investor Relations, Business Development & Special Events

Massimo Radaelli M.B.A., Ph.D.

President of Jaguar International

David Sesin Ph.D.

Chief Manufacturing Officer

Pravin R. Chaturvedi Ph.D.

Chief Scientific Officer & Chair of Scientific Advisory Board

Jonathan S. Wolin CPA, J.D., M.B.A.

Chief of Staff, Chief Compliance Officer & General Counsel

Management

Ian H. Wendt M.B.A.

Chief Commercial Officer

Lisa A. ConteCEO

Founder, Chief Executive Officer, President & Director

Karen J. Brunke Ph.D.

Executive Vice President of Corporate & Business Development

Peter HodgeCTO

Senior Director of Investor Relations, Business Development & Special Events

Massimo Radaelli M.B.A., Ph.D.

President of Jaguar International

David Sesin Ph.D.

Chief Manufacturing Officer

Pravin R. Chaturvedi Ph.D.

Chief Scientific Officer & Chair of Scientific Advisory Board

Jonathan S. Wolin CPA, J.D., M.B.A.

Chief of Staff, Chief Compliance Officer & General Counsel

Total 8 executives

JAGX Frequently asked questions

What is Jaguar Health, Inc. (JAGX) Stock Price?

Current stock price of Jaguar Health, Inc. (JAGX) stock is $0.730. The stock price is -0.15% lower in the session. The intraday range can be seen from this page. Volume of Jaguar Health, Inc. (JAGX) stock is 118.62K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Jaguar Health, Inc. (JAGX) stock price going up or down today?

The stock price of Jaguar Health, Inc. (JAGX) can change with earnings, company news, and overall market sentiment. Jaguar Health, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Jaguar Health, Inc. stock expensive at its current price?

Whether Jaguar Health, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for JAGX on this page is -0.02. EPS on this page is -43.74. Compare those figures with peers and growth expectations before deciding if the current Jaguar Health, Inc. price is justified.

How has the stock price of Jaguar Health, Inc. (JAGX) performed historically?

Historical performance for Jaguar Health, Inc. (JAGX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how JAGX reacted to past earnings and market events.

Should I buy Jaguar Health, Inc. (JAGX) stock, at this price?

Buying Jaguar Health, Inc. (JAGX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.